Paul C H Li
Dr. Paul Li obtained his Ph.D in analytical chemistry at the University of Toronto in 1995. Then he developed the microfluidic lab-on-a-chip at the University of Alberta during his postdoctoral work. Dr. Li became assistant professor at City University of Hong Kong in 1996, and then he joined Simon Fraser University in 1999, and he was promoted to full professor in 2010. Dr. Li is interested in using nanomaterials to construct chemical sensors. He also employs microfluidic nanotechnology for single-cell analysis (cancer cell drug uptake) and bioarray detection of trace amounts of nucleic acid materials (fungal pathogenic DNA, Kras cancer gene DNA, and influenza viral RNA). Dr. Li has other research interests on immunoassay chip, C11 radiotracer synthesis, and F18 enrichment as well. He has published a monograph: Fundamentals of lab on a chip for biological analysis and discovery in 2010, and a book chapter in Nanopatterning and Nanoscale Devices for Biological Applications in 2014. He is associate editor of Canadian Journal of Pure and Applied Sciences, and sits on the editorial boards of Journal of Proteomics and Genomics, and Hong Kong Pharmaceutical Journal. Dr. Li is the inventor of 4 granted patents and 5 pending patents, and he is the founder and vice president of ZellChip Technologies Inc. specializing in microfluidic-based instruments for life science applications.